David Do is an Assistant Professor of Clinical Neurology at the University of Pennsylvania (Perelman School of Medicine), while also serving as Assistant Chief Medical Information Officer at Penn Medicine and Innovation Manager at the Center for Health Care Innovation. His work integrates clinical neurology with software development and design thinking to optimize healthcare analytics and clinical operations. University: University of Pennsylvania Department: Clinical Neurology Roles: Assistant Professor, Assistant CMIO for Data and Analytics, Innovation Manager His research focuses on: Microfluidic platforms for clinical diagnostics Extracellular vesicle-based biomarkers for neurological and oncological conditions RNA delivery systems using lipid nanoparticles Development of scalable and high-throughput diagnostic technologies Integration of data analytics in clinical workflows Recent publications highlight trends in: Single-vesicle analysis for clinical diagnostics Optimization of lipid nanoparticle formulations for mRNA delivery Microfluidic device applications for cancer treatment and neurodegenerative disease detection Advanced characterization techniques for nanoparticle properties Scalable manufacturing of biomedical devices and formulations
Dr. Yakov Woldman is a Professor in the Department of Chemistry at Valdosta State University. He teaches freshman chemistry I and II (with labs), honors chemistry (with labs), and biochemistry I and II (with labs). His research focuses on detecting reactive oxygen and nitrogen species in biological systems, particularly through chemiluminescence and quantitative analysis of cellular reactive species generation. Research Interests: Detection of reactive oxygen/nitrogen species in biological systems Quantitative assessment of reactive species generation by cells Development of chemiluminescence-based detection methods Design of pH-sensitive nanoprobes for biomedical applications Publications highlight his work in nitric oxide detection, chemiluminescence techniques, and nanoparticle-based analytical tools.
Kwon Seong-won is a Professor at the Department of Pharmacy, College of Pharmacy, Seoul National University, where he has held continuous faculty appointments since 2005. His academic foundation was established entirely at Seoul National University, culminating in a PhD in Pharmacy in 2001 after completing BS (1996) and MS (1998) degrees there. Prior to his faculty appointment, he conducted postdoctoral research at Indiana University (2001-2002) and Southwestern Medical Center (2002-2005). Education PhD in Pharmacy, Seoul National University (2001) MS in Pharmacy, Seoul National University (1998) BS in Pharmacy, Seoul National University (1996) Professor Kwon's research centers on advanced mass spectrometry applications in biological systems. His primary focus areas— Mass Spectrometry-Based Metabolomics , Single Cell Spatial Lipidomics , and Bioanalytical Method Development —converge on understanding metabolic and lipidomic alterations at cellular and molecular levels. His work bridges analytical chemistry with disease mechanisms, particularly in oncology, immunology, and nanotoxicology, emphasizing translational applications for drug analysis and disease diagnostics. Analysis of his 2018-2024 publications reveals a consistent trajectory in multi-omics approaches to complex biological problems. His research spans thyroid cancer metabolic phenotyping, nanoparticle toxicity mechanisms, tumor microenvironment remodeling, and rheumatoid arthritis lipidomics. A unifying theme is the application of spatial lipidomics and metabolomics to uncover disease-specific metabolic signatures, with strong emphasis on nanomaterial-biological interactions and immune-metabolic crosstalk. Scientific Awards No specific awards were documented in the source materials. While student mentorship details are absent from the provided information, his prolific publication record in high-impact journals (including Nature Communications and ACS Nano) indicates active supervision of graduate researchers. His laboratory operations, referenced by lab fax (886-7844), support advanced mass spectrometry workflows for lipidomic and metabolomic analyses at Seoul National University.
Susan M. Lunte is the Ralph N. Adams Distinguished Professor of Chemistry and Pharmaceutical Chemistry and Director of the Adams Institute for Bioanalytical Chemistry and the NIH COBRE Center for Molecular Analysis of Disease Pathways at the University of Kansas School of Pharmacy. Her research bridges neurobiology, analytical chemistry, and bioengineering. Education: B.A. from Kalamazoo College (1980), Ph.D. from Purdue University (1984) Research interests focus on bioanalytical methods for blood-brain barrier peptide transport, microdialysis-coupled microchip electrophoresis, and cell-based assays for oxidative stress markers. Projects include chip-based clinical diagnostics for heart disease and on-animal sensors for neurotransmitter monitoring. Recent publications highlight advancements in microfluidic devices for in vivo neurochemical analysis, carnosine’s anti-inflammatory properties, and portable electrochemical detection systems. Key subfields include neuroactive peptides, drug metabolism, and biomedical microsystems. She leads the Lunte Research Group, which develops miniaturized sensors for freely moving animals and clinical diagnostics. Research facilities include the Multidisciplinary Research Building and NIH-funded infrastructure.
Ashutosh Kumar Mishra is an Associate Professor in the Department of Chemistry at the Indian Institute of Technology Hyderabad (IIT-Hyderabad). His research group focuses on bioorganic chemistry, sensor development, and nanoscience, with particular emphasis on designing flavin-based molecular probes for biomedical and energy applications. Education: Ph.D. in Chemistry from IIT Kanpur Postdoctoral training at Northwestern University, USA M.Sc. from D.D.U. Gorakhpur University Research Focus: Dr. Mishra's work spans the development of flavin-derived fluorescent probes for real-time monitoring of cellular oxidants (e.g., hypochlorous acid), stimuli-responsive supramolecular materials, and bioinspired electrode systems for energy storage. His group specializes in mitochondrial-targeted bioimaging and multi-stimuli responsive materials. Recent Publications: His most recent articles (2022-2025) demonstrate strong themes in flavin-based probe design, with applications spanning from real-time cellular imaging of reactive oxygen species to organic electrode materials. The works frequently integrate synthetic chemistry with advanced biomedical applications and materials characterization. Honors: Research Excellence Award-2022 IIT-Hyderabad Best Poster Award-2024 Best Poster Award at IC-AIE-FA 2022 Research Group: Leads an active team including doctoral students (Harsha Gopal Agrawal, Vaibhav, others) and postdoctoral researchers (Dr. MSSV Mouli). Recent achievements include doctoral thesis defenses, international postdoc placements, and conference awards. Funded by SERB India (CRG/2022/006706).
John Kalu Osiri serves as Associate Professor of Practice in Management and Director of the International Business Program at the University of Nebraska-Lincoln's College of Business, where he is also a Robert B. Daugherty Water For Food Institute Faculty Fellow. A global educator and executive leadership coach, he integrates academic rigor with practical business experience across international contexts. His educational credentials include a Management Development Program from Harvard University, an AACSB-sanctioned Post-Doctorate in International Business and Entrepreneurship from the University of Florida, a Ph.D. in Bioanalytical Chemistry from Louisiana State University, and a B.S. in Chemistry (with minors in Biology and Mathematics) from Grambling State University. Osiri's research centers on decolonizing management practices through African indigenous knowledge systems, with significant focus on Igbo management philosophy and cross-cultural leadership. He investigates how cultural contexts shape entrepreneurial intentions, social media's impact on consumer behavior and workplace productivity, and sustainable development frameworks in African and Indian contexts. His work bridges neurochemistry of leadership with practical applications for organizational change. His recent publications reveal a clear trajectory toward decolonizing business scholarship, examining pandemic impacts in Sub-Saharan Africa, sustainable energy solutions, and the symbiotic relationship between innovation and entrepreneurship through culturally grounded lenses. Notable recognitions include the Chancellor’s Fulfilling the Dream Award (2018) for expanding global student opportunities and his Water For Food Institute fellowship. As Doctoral Faculty Associate, Osiri mentors graduate students and serves on dissertation committees. He previously directed faculty-led study abroad programs in Spain and France, and actively contributes to university governance through committees focused on equity in faculty evaluation and pandemic response leadership. His community engagement includes founding the Afrikan Community of Nebraska and serving on credit union boards. He founded Osiri University to address educational disparities in Africa and authored "Unleashing Your Idea" and "Entrepreneurial Marketing," while maintaining active roles in the Academy of International Business and Consortium for Undergraduate International Business Education.
Professor Facundo Fernández is a faculty member at the Georgia Institute of Technology within the School of Chemistry and Biochemistry , holding the academic rank of Professor. His research spans bioanalytical mass spectrometry, metabolomics, bioinformatics, ambient sampling/ionization techniques, and multidimensional instrumentation development, with applications in ovarian cancer, lipidomics, and cardiovascular disease. Education: Not explicitly mentioned in available text. Key Research Interests: Mechanobiology of vascular systems, microRNA regulation in valvular diseases, imaging mass spectrometry, and inter-laboratory metabolomics standardization. Scientific Awards: Recipient of the ACS 2025 Advances in Measurement Science Lectureship Award . Students: Advised Ph.D. graduates Alex Van Grouw and Dr. Dmitry Leontyev, with ongoing mentorship of current students. Laboratory: Established in 2004, the Fernández Lab focuses on chemical evolution, cell-based therapeutics, and advanced mass spectrometry instrumentation for biochemical analysis.
Olivier Barbier is a Full Professor and currently serves as Vice-Dean for Research and Graduate Studies at the Faculty of Pharmacy, Université Laval. His academic career spans over 15 years with significant contributions in pharmacology, particularly in the field of glucuronidation and its role in liver diseases, cardiovascular disorders, and prostate cancer. As Vice-Dean, he oversees research initiatives and graduate programs at one of Canada's leading pharmacy faculties. Dr. Barbier's educational journey began with a Bachelor's degree in cell biology and physiology from François-Rabelais University in Tours, France, followed by a Master's degree in environmental sciences from Bordeaux I University. He completed his DEA in toxic interactions from University of Paris VII, earned his Doctorate in Physiology-Endocrinology from Laval University, and conducted post-doctoral research in lipidology and atherosclerosis at INSERM Unit in Lille, France. His research focuses on three primary areas: glucuronidation and liver diseases, cardiovascular diseases, and prostate cancer. Dr. Barbier's laboratory investigates how UDP-glucuronosyltransferase (UGT) enzymes metabolize bile acids, bilirubin, and androgens, with the goal of identifying novel therapeutic approaches. His work has demonstrated that fibrates and LXR activators stimulate bile acid glucuronidation in human liver cells, potentially offering new treatments for cholestatic liver diseases. He has also explored how omega-3 fatty acids and their derivatives like Protectin DX can enhance therapeutic responses to existing medications. Analysis of Dr. Barbier's recent publications reveals a strong emphasis on bile acid metabolism, particularly the role of glucuronidation in detoxification processes. His research increasingly incorporates nutraceutical approaches, combining omega-3 fatty acids with conventional therapeutics to improve treatment outcomes for liver diseases. There's also a growing focus on environmental toxicology, examining how metal exposure affects kidney function, particularly in pediatric populations. Dr. Barbier has successfully secured funding from major sources including the Canadian Institutes of Health Research (CIHR), Heart and Stroke Foundation of Canada, Pharmaceutical Research and Manufacturers of Canada (Rx&D), and Pfizer Canada. His laboratory supports numerous graduate students and research professionals, contributing significantly to the training of the next generation of pharmacologists and toxicologists. As head of the Molecular Pharmacology Laboratory and co-director of the Bioanalytical Services with Dr. Chantal Guillemette, Dr. Barbier oversees sophisticated analytical capabilities including HPLC, GC/MS, and LC/MS/MS systems. His laboratory provides specialized services for hormone quantification and drug metabolism studies, supporting both academic and pharmaceutical research. The lab's expertise in measuring steroid hormones and their metabolites at picogram levels represents a significant technical achievement in the field of bioanalysis.
Szymon Mikolaj Szostak serves as a PhD Research Fellow in the Department of Chemistry at the University of Oslo's Faculty of Mathematics and Natural Sciences. He is affiliated with the Section for Chemical Life Sciences (Biomolecules, Bio-inspired Materials and Bioanalytics) and the Bio3 Research Group for Soft Matter & Scattering Methods, with his workspace in Room Ø214 at Sem Sælands vei 26. His academic foundation includes a Master's degree in Chemistry (2019–2021) and Bachelor's degree in Chemistry (2016–2019), both from the University of Warsaw. These qualifications underpin his current doctoral research trajectory focused on advanced nanomaterial design. Szostak's research centers on self-assembled nanostructures and sequence-defined peptoids, with specialized expertise in nanoparticle drug delivery systems. His work bridges nanomaterials synthesis, polymer physics, and biomedical applications, emphasizing controlled molecular assembly for therapeutic purposes. Key methodologies include soft matter characterization and bio-inspired material engineering. His 2024–2025 publications reveal a cohesive research trajectory in polymeric micelle thermodynamics, hydrogel sterilization protocols, and coacervation kinetics – demonstrating consistent innovation at the intersection of colloid science, pharmaceutical technology, and biomaterials engineering. These studies collectively advance fundamental understanding of nanostructure confinement effects and functional property optimization. As an active contributor to the Bio3 Research Group, Szostak participates in collaborative investigations utilizing scattering methods to probe soft matter systems, particularly focusing on structure-property relationships in biomimetic materials.
Achilleas Garoufis is a full Professor in the Department of Chemistry at the University of Ioannina, where he has served since 2015 after progressing through academic ranks from Lecturer (2000) to Assistant Professor (2005) and Associate Professor (2010). His primary appointment resides within the Chemistry department with no explicit school affiliation mentioned in available materials. His research spans inorganic and bioinorganic chemistry with emphasis on metal-based anticancer agents. Garoufis' research program focuses on the design and characterization of platinum group metal complexes (particularly ruthenium, palladium, and platinum) conjugated to biomolecules. His work investigates DNA binding mechanisms using spectroscopic and bioanalytical techniques, with applications in photodynamic therapy and cytostatic drug development. Key methodologies include NMR, CD, LD spectroscopy, electrophoresis, and ESI-MS for studying metal-nucleic acid interactions. Analysis of his 15 most recent publications (2021-2025) reveals consistent focus on ruthenium and platinum anticancer complexes, DNA binding specificity, and photophysical properties of supramolecular structures. His work increasingly incorporates advanced structural characterization of metal complexes with DNA oligomers and explores novel scaffolds like cycloparaphenylene systems for enhanced cytotoxicity. Recent publications also demonstrate expansion into analytical applications of NMR for food chemistry, particularly olive oil authentication. Garoufis has authored several textbooks including Inorganic elements in the environment, life and technology (2005) and Inorganic Chemistry (1999), and has translated Cotton & Wilkinson's BASIC INORGANIC CHEMISTRY . His teaching portfolio covers undergraduate and graduate courses in Inorganic Chemistry, Bioinorganic Chemistry, Mass Spectrometry, and NMR Spectroscopy. His academic development includes undergraduate and doctoral studies at the University of Ioannina (BSc 1985, PhD 1989), followed by postdoctoral work at the University of Bergen (1993-1994), VUB Brussels (1994-1995), and Zhongshun University (1999). Current research continues to advance metal-based therapeutic strategies with emphasis on structure-activity relationships in DNA-targeting complexes.
Julie A Stenken serves as Professor of Analytical Chemistry and holder of the 21st Century Chair in Proteomics within the Department of Chemistry & Biochemistry at the University of Arkansas' College of Arts and Sciences. With 23 years of teaching experience since joining the university in 2007 (previously at Rensselaer Polytechnic Institute), she is recognized globally as a leading expert in microdialysis sampling for macromolecular compounds. Her academic credentials include: B.S. in Chemistry from the University of Akron (1990) Ph.D. in Bioanalytical Chemistry from the University of Kansas (1995) J. William Fulbright Fellowship at The Karolinska Institute, Stockholm (1994-1995) Postdoctoral Fellowship at the University of Kansas Medical School (1995-1996) Dr. Stenken's pioneering research focuses on in vivo sensing methodologies and device manufacture for biochemical measurement in living systems. Her work integrates bioanalytical chemistry , bioengineering , and biomaterials science to develop advanced techniques for cytokine monitoring in brain and subcutaneous tissues. As a world authority on microdialysis applications for macromolecules, her innovations address critical challenges in implantable sensor development and inflammatory response characterization. Analysis of her 2010-2015 publications reveals consistent advancement in microdialysis technology, with emphasis on cytokine measurement in neural environments, adipose tissue, and inflammatory sites. Her work demonstrates sophisticated integration of affinity techniques, mathematical modeling, and biomaterials engineering to overcome sampling limitations in complex biological matrices. Scientific recognition includes: J. William Fulbright Fellow (1994-1995) Dr. Stenken directs an interdisciplinary research group investigating macrophage-mediated inflammatory responses to implanted biomaterials. Her team employs chromatographic, immunochemical, and spectroscopic methods to analyze microdialysis dialysates, with current projects targeting cytokine dynamics during inflammation, matrix metalloproteinase detection via imaging mass spectrometry, and enhanced microdialysis mass transport modeling. While specific grant details aren't documented, her sustained publication record in premier journals indicates substantial research funding. The Stenken Laboratory operates at the intersection of chemistry, engineering, and neuroscience, maintaining collaborative networks across biomedical disciplines to advance in vivo analytical capabilities for clinical applications.
Erik Andrew Johannessen serves as Professor in the Department of Microsystems within the Faculty of Technology, Natural Sciences and Maritime Sciences at the University of South-Eastern Norway (USN), based at Campus Vestfold. His responsibilities include teaching foundational courses in BioMEMS and engineering professional practice while leading research at the convergence of microsystems engineering and biological applications. His research program centers on exploiting nanostructured materials and microsystem technology to decode fundamental biological processes and engineer advanced bioanalytical devices. Key focus areas include developing BioMEMS platforms that integrate organic materials with solid-state electronics through nature-inspired design principles, enabling breakthroughs in cell manipulation, targeted therapeutic delivery, and precision diagnostics through strategic miniaturization. Technical mastery spans photolithographic/e-beam microfabrication, primary cell culture techniques, electrochemical sensor development, multi-language programming (Python/Pascal), analogue circuit design, and autonomous physiological monitoring instrumentation. This interdisciplinary skillset facilitates the creation of integrated microsystems that translate molecular recognition mechanisms into functional biomedical devices for real-world healthcare applications.
Claudia Grewe is a Professor in the Department of Applied Biosciences and Process Engineering at Anhalt University of Applied Sciences, where she serves as Degree Program Advisor for the Biotechnology Bachelor of Engineering program (offered in both full-time and dual study formats). Her academic career spans from her earliest publications in 2007 through to recent work in 2024, demonstrating sustained research activity in microalgae biotechnology. Professor Grewe's research interests center on microalgae biotechnology with particular expertise in lipid extraction, carotenoid production, and downstream processing of high-value compounds. Her work integrates analytical chemistry methods with bioprocess engineering to develop comprehensive approaches for characterizing and processing microalgal biomass. She has made significant contributions to the development of analytical methods for glycerolipidome profiling and the optimization of extraction processes for both lipophilic and hydrophilic compounds from microalgae. Analysis of her publication record from 2007-2024 reveals a consistent research trajectory focused on microalgae applications, with increasing emphasis on multiproduct recovery systems and analytical method development in recent years. Her work spans fundamental studies of carotenoid biosynthesis under different cultivation conditions to applied research on commercial-scale microalgal cultivation systems and downstream processing. As an academic advisor, Professor Grewe guides students in the Biotechnology program, likely incorporating her research expertise into practical learning experiences. Her work on microalgae as multiproduct cell factories provides valuable context for students interested in sustainable biotechnology and renewable resource utilization. Based at the Köthen campus of Anhalt University of Applied Sciences, Professor Grewe conducts her research and teaching within the Department of Applied Biosciences and Process Engineering, contributing to the university's focus on applied scientific research with industrial relevance.
Dr. Justyna Rechthaler is a Research Associate at the University of Applied Sciences Wiener Neustadt, specifically based at the Biotech Campus Tulln. She specializes in Chromatography & Mass Spectrometry and contributes to the Master's Program in Bio Data Science. Her research focuses on proteomics, metabolomics, and bioinformatics applications across multiple domains. Dr. Rechthaler leads and contributes to several significant research projects including CIM (Tumor stroma analysis using nano LC-MS/MS), Myko-Ten (investigating mealworms for mycotoxin degradation), and OMICS 4.0 (bioinformatics in life science research). Her work combines advanced analytical techniques with computational approaches to address complex biological questions. Analysis of her recent publications (2022-2024) reveals a strong focus on optimizing protein identification in proteomics, particularly for insect models, with emphasis on sample preparation techniques and data processing methodologies. She also publishes extensively on metabolomics approaches for studying plant-pathogen interactions and novel microbial species with pharmaceutical potential. Her scientific contributions demonstrate expertise in: Nano LC-MS/MS methodologies Proteomics and metabolomics data analysis Mycotoxin research and food safety Cancer diagnostics and tumor microenvironment analysis Interdisciplinary bioinformatics approaches Dr. Rechthaler maintains active research collaborations, particularly with the University of Applied Sciences IMC Krems on cancer diagnostics projects that combine Raman microscopy with artificial intelligence. Her work bridges analytical chemistry, bioinformatics, and practical applications in healthcare and food safety. Her laboratory, known as Ra-Dia_M, focuses on advanced analytical techniques for biological research, particularly in the areas of proteomics and metabolomics, supporting multiple research projects across different scientific domains.
Juho Heininen is a Doctoral Researcher at the Department of Pharmaceutical Biosciences , University of Helsinki, Finland. He is affiliated with the Doctoral Programme in Drug Research and contributes to interdisciplinary projects bridging pharmaceutical sciences with agricultural biotechnology. PhD candidate in Pharmaceutical Chemistry Active in chemical proteomics and metabolomics research Research Focus: His work spans three primary areas: Development of isobaric labeling techniques for metabolite quantitation in single cells Exploration of dairy industry byproducts in pharmaceutical manufacturing Investigation of photosynthetic adaptations in indoor crop production systems Publication Trends: Over 2021-2025, Heininen has published 5 peer-reviewed articles focusing on analytical methodology, drug delivery systems, and plant-pharma intersections. His recent work emphasizes precision agriculture applications of pharmaceutical research tools. Advising & Grants: He supervised Sara Kavilo's BSc thesis and participates in two funded projects: Akatemiahanke Chemical proteomics (Academy of Finland, 2024-2028) Orion Research Foundation project (2023-2024)
